H-D-HoPro-OMe.HCl

Catalog No. :
ACXGQS538
CAS No. :
18650-38-9
Molecular Formula :
C7H14ClNO2
Molecular Weight :
179.65

IUPAC Name:methyl (R)-piperidine-2-carboxylate hydrochloride

H-D-HoPro-OMe.HCl structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$81.00Login to see priceIn stockInquiry
100g95%$297.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameH-D-HoPro-OMe.HCl
IUPAC Namemethyl (R)-piperidine-2-carboxylate hydrochloride
MDL No.MFCD00237412
Molecular FormulaC7H14ClNO2
Molecular Weight179.65
SMILESCl.COC(=O)[C@H]1CCCCN1
InChI KeyAPCHKWZTSCBBJX-FYZOBXCZSA-N
Synonym18650-38-9 | (R)-PIPERIDINE-2-CARBOXYLIC ACID METHYL ESTER HYDROCHLORIDE | H-D-HoPro-OMe.HCl | (R)-Methyl piperidine-2-carboxylate hydrochloride | methyl (2R)-piperidine-2-carboxylate hydrochloride | Methyl (R)-piperidine-2-carboxylate hydrochloride | methyl (2R)-pip
CAS No.18650-38-9
PubChem CID49759143

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXGQS538 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACTUQX702 route compound structure diagram
    ACTUQX7021723-00-8 In Stock
  4. Then
  5. ACXGQS538 route product structure diagram
    ACXGQS53818650-38-9 In Stock
Inquiry

2. ACXGQS538 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACTUQX702 route compound structure diagram
    ACTUQX7021723-00-8 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACXGQS538 route product structure diagram
    ACXGQS53818650-38-9 In Stock
Inquiry

Comments (0)